R. Locklin

发表

Enhanced osteoblastogenesis in three-dimensional collagen gels.

P. Hulley, J. Cornish, K. Callon, 2014, BoneKEy reports.

Stimulation of osteoclast formation by inflammatory synovial fluid

N. Athanasou, A. Sabokbar, I. Adamopoulos, 2006, Virchows Archiv.

Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone

B. L. Riggs, S. Khosla, R. Turner, 2003, Journal of cellular biochemistry.

Innate immune response to human bone marrow fibroblastic cell implantation in CB17 scid/beige mice

S. Gordon, P. Taylor, Z. Cui, 2006, Journal of cellular biochemistry.

Agonists of TRAIL death receptors induce myeloma cell apoptosis that is not prevented by cells of the bone marrow microenvironment

P. Croucher, R. Russell, C. Edwards, 2007, Leukemia.

MODULATION OF OSTEOGENIC DIFFERENTIATION IN HUMAN SKELETAL CELLS IN VITRO BY 5‐AZACYTIDINE

R. Oreffo, J. Triffitt, R. Locklin, 1998, Cell biology international.

Effects of TGFβ and BFGF on the differentiation of human bone marrow stromal fibroblasts

R. Oreffo, J. Triffitt, R. Locklin, 1999, Cell biology international.

LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid arthritis.

J. Edwards, N. Athanasou, A. Sabokbar, 2006, Arthritis and rheumatism.

Selective targeting of death receptor 5 circumvents resistance of MG-63 osteosarcoma cells to TRAIL-induced apoptosis

P. Hulley, R. Russell, E. Federici, 2007, Molecular Cancer Therapeutics.

Lactoferrin protects osteoblasts and osteocytes from apoptosis

P. Hulley, J. Cornish, D. Naot, 2009 .

Evidence of cis-acting regulatory variation in PTPN22 in patients with rheumatoid arthritis

Pille Harrison, Jennifer J. Pointon, L. Southam, 2012, Scandinavian journal of rheumatology.

A gain-of-function mutation of Fgfr2c demonstrates the roles of this receptor variant in osteogenesis.

Gillian M Morriss-Kay, V. P. Eswarakumar, G. Morriss-Kay, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Differences between bisphosphonates in binding affinities for hydroxyapatite.

J. Dunford, R. Russell, J. Triffitt, 2010, Journal of biomedical materials research. Part B, Applied biomaterials.

Assessment of Gene Regulation by Bone Morphogenetic Protein 2 in Human Marrow Stromal Cells Using Gene Array Technology

B. L. Riggs, M. Byrne, S. Khosla, 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Efficient characterisation of human cell-bioceramic interactions in vitro and in vivo by using enhanced GFP-labelled mesenchymal stem cells.

D. Ferguson, Z. Cui, H. Ye, 2005, Biomaterials.

In vitro effects of growth factors and dexamethasone on rat marrow stromal cells.

J. Triffitt, J. Beresford, M. Williamson, 1995, Clinical orthopaedics and related research.

Potential bone mineral binding differences among bisphosphonates can be demonstrated by the use of hydroxyapatite column chromatography.

J. Triffitt, F. Ebetino, R. Phipps, 2005 .

Fates and osteogenic differentiation potential of human mesenchymal stem cells in immunocompromised mice.

J. Triffitt, Z. Xia, R. Locklin, 2008, European journal of cell biology.